Wyeth, GSK Adult Pneumococcal Vaccines Need More Serotypes For Approval

Manufacturers should design pneumococcal conjugate vaccines for adults with more serotypes to show non-inferiority to the currently marketed 23-valent polysaccharide vaccine, FDA's Vaccines & Related Biological Products Advisory Committee suggested at its Nov. 17 meeting